Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Nasal Midazolam for Vasectomy Sedation
NCT06449365Phase 4Completed
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start
- Oct 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of midazolam in Procedural sedation (PS) (2 arms), sponsored by University of Tennessee Graduate School of Medicine. Primary endpoint: Patient Questionnaire (Anxiety, Discomfort, Pain, Sedation Length) at 1 year. Started Oct 2017; status: completed.
02
Drugs
midazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT06449365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06449365.